Topics

Roche plans trial for Actemra as COVID-19 treatment

08:16 EDT 25 Mar 2020 | SmartBrief

Roche has secured FDA approval to launch a late-stage trial by early April to assess the efficacy of its drug Actemra, or toc -More

Original Article: Roche plans trial for Actemra as COVID-19 treatment

NEXT ARTICLE

More From BioPortfolio on "Roche plans trial for Actemra as COVID-19 treatment"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...